These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10182223)

  • 21. Drug combination shows benefits for AIDS patients with history of taking AZT.
    AIDS Patient Care STDS; 1996 Jun; 10(3):185-6. PubMed ID: 11361628
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxic uveitis caused by pharmacodynamic interactions of Rifabutin and protease inhibitors: a case report.
    Ebraert H; Salu P
    Bull Soc Belge Ophtalmol; 2007; (303):57-60. PubMed ID: 17894289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hygienic basis of the prevention of AIDS (review of the literature)].
    Lalaiants IE; Milovanova LS
    Gig Sanit; 1990 Dec; (12):72-6. PubMed ID: 2093038
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of HIV/AIDS. New possibilities result in new problems].
    Nielsen JO
    Ugeskr Laeger; 1998 Jun; 160(23):3371. PubMed ID: 9627502
    [No Abstract]   [Full Text] [Related]  

  • 25. The good news about AIDS.
    Indian J Med Sci; 1997 Jun; 51(6):208. PubMed ID: 9355726
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunologic restoration in patients with AIDS. Requiem for prophylaxis].
    Peña JM; Miró JM
    Med Clin (Barc); 1999 Oct; 113(10):375-8. PubMed ID: 10562941
    [No Abstract]   [Full Text] [Related]  

  • 27. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral therapy for infection due to human immunodeficiency virus in children.
    Pizzo PA; Wilfert C
    Pediatr AIDS HIV Infect; 1994 Oct; 5(5):273-95. PubMed ID: 11361369
    [No Abstract]   [Full Text] [Related]  

  • 30. ACTG 320 trial halted as three-drug arm proves superior.
    AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361796
    [No Abstract]   [Full Text] [Related]  

  • 31. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
    Persaud D; Palumbo P; Ziemniak C; Chen J; Ray SC; Hughes M; Havens P; Purswani M; Gaur AH; Chadwick EG;
    J Infect Dis; 2007 May; 195(10):1402-10. PubMed ID: 17436219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy.
    Parkin NT; Lie YS; Hellmann N; Markowitz M; Bonhoeffer S; Ho DD; Petropoulos CJ
    J Infect Dis; 1999 Sep; 180(3):865-70. PubMed ID: 10438382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolution of disseminated molluscum contagiosum with Highly Active Anti-Retroviral Therapy (HAART) in patients with AIDS.
    Calista D; Boschini A; Landi G
    Eur J Dermatol; 1999; 9(3):211-3. PubMed ID: 10210787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of didanosine in the management of HIV-1 infection.
    Gazzard BG; Moyle GJ
    Antivir Ther; 1997 Jul; 2(3):135-47. PubMed ID: 11322269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
    James JS
    AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3TC approval may revive AZT's appeal.
    Vazquez E
    Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AZT indication extended to use in children.
    J Am Osteopath Assoc; 1990 Jan; 90(1):16, 19. PubMed ID: 2312366
    [No Abstract]   [Full Text] [Related]  

  • 38. Protease inhibitors and prevention of cross resistance.
    Levin J
    AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saquinavir thwarts resistance.
    AIDS Alert; 1995 Oct; 10(10):123. PubMed ID: 11362782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research study of combination AIDS therapies underway.
    AIDS Patient Care STDS; 1996 Apr; 10(2):132. PubMed ID: 11361697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.